Infections and anti-TNF therapy: Strategies for screening based on clinical experience (multiple letters) [11]

Rheumatology

Volumn 43, Issue 1, 2004, Pages 115-116

  Estrach, C ^a   Abernethy, V E ^b   Dawson, J K ^b   Kroesen, S ^c   Widmer, A F ^c   Tyndall, A ^c   Hasler, Paul ^c  

^a Countess of Chester Hospital ^*  (United Kingdom)

^b St Helens Hospital   (United Kingdom)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; TUMOR NECROSIS FACTOR ANTIBODY;

ANAMNESIS; BRONCHIECTASIS; BRONCHOSCOPY; COST BENEFIT ANALYSIS; DEATH; DISEASE SEVERITY; DRUG USE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HOSPITALIZATION; HUMAN; INFECTION SENSITIVITY; LETTER; MEDICAL DECISION MAKING; MEDICAL SOCIETY; PATIENT ATTITUDE; PATIENT INFORMATION; PHYSICIAN ATTITUDE; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RHEUMATOID ARTHRITIS; SAFETY; SCREENING TEST; SPUTUM ANALYSIS; THORAX DISEASE; THORAX RADIOGRAPHY;

BACTERIAL INFECTIONS; BIOLOGICAL RESPONSE MODIFIERS; HUMANS; IMMUNOGLOBULIN G; PATIENT SELECTION; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0347093501     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg484     Document Type: Letter

References (0)